PubRank

Timothy J Collier

Author PubWeight™ 34.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 2004 4.69
2 The role of alpha-synuclein in Parkinson's disease: insights from animal models. Nat Rev Neurosci 2003 1.92
3 Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur J Neurosci 2010 1.51
4 The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J 2011 1.34
5 Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. Neurobiol Dis 2011 1.21
6 Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability. J Comp Neurol 2007 1.11
7 Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Ann Neurol 2006 1.08
8 Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease. J Comp Neurol 2009 1.01
9 Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol Dis 2005 1.01
10 Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats. Mov Disord 2003 0.99
11 Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex. J Parkinsons Dis 2011 0.97
12 Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease. Brain Res 2007 0.95
13 Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys. Glia 2008 0.93
14 Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease. Brain Res 2005 0.91
15 Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons. J Neurochem 2002 0.91
16 Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. J Comp Neurol 2003 0.90
17 Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model. Mol Ther 2011 0.88
18 Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats. J Comp Neurol 2009 0.87
19 Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys. Neurobiol Aging 2008 0.86
20 Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain. J Neurosci Methods 2013 0.85
21 Reassessment of caspase inhibition to augment grafted dopamine neuron survival. Cell Transplant 2004 0.85
22 Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells. Exp Neurol 2003 0.84
23 Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. Mov Disord 2012 0.83
24 Cellular repair in the parkinsonian nonhuman primate brain. Rejuvenation Res 2010 0.83
25 A synergistic approach for neural repair: cell transplantation and induction of endogenous precursor cell activity. Neuropharmacology 2009 0.82
26 Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons. J Neurosci Methods 2007 0.82
27 Endogenous neural precursors influence grafted neural stem cells and contribute to neuroprotection in the parkinsonian rat. Eur J Neurosci 2012 0.82
28 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture. Neuropharmacology 2008 0.80
29 Agonists of the tissue-protective erythropoietin receptor in the treatment of Parkinson's disease. Curr Top Med Chem 2015 0.80
30 Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems. J Neurosci Res 2005 0.79
31 Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Brain Res 2006 0.77
32 Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons. Nutr Neurosci 2007 0.76
33 An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality. Exp Neurol 2004 0.76
34 A potential compensatory role for endogenous striatal tyrosine hydroxylase-positive neurons in a nonhuman primate model of Parkinson's disease. Cell Transplant 2015 0.75